Abstract: Escherichia coli (E. coli) remains the most efficient widely-used host for recombinant protein production. Well-known genetics, high transformation efficiency, cultivation simplicity, rapidity and inexpensiveness are the main factors that contribute to the selection of this host. With the advent of the post-genomic era has come the need to express in this bacterium a growing number of genes originating from different organisms. Unfortunately, many of these genes severely interfere with the survival of E. coli cells. They lead to bacteria death or cause significant defects in bacteria growth that dramatically decrease expression capabilities. In this paper, we review special strategies and genetics tools successfully used to express, in E. coli, highly toxic genes. Suppression of basal expression from leaky inducible promoters, suppression of read-through transcription from cryptic promoters, tight control of plasmids copy numbers and proteins production as inactive (but reversible) forms are among the solutions presented and discussed. Special expression vectors and modified E. coli strains are listed and their effectiveness illustrated with key examples, some of which are related to our study of the highly toxic phage T4 restriction endoribonuclease RegB. We mainly selected those strategies and tools that permit E. coli normal growth until the very moment of highly toxic gene induction. Expression then occurs efficiently before cells die. Because they do not target a particular toxic effect, these strategies and tools can be used to express a wide variety of highly toxic genes.
INTRODUCTION
Recombinant protein production in E. coli takes advantages of the extensive knowledge on the genetics and the molecular biology of the bacterium. Although general strategies for achieving high-level expression of genes in this organism have been heavily reviewed [1] [2] [3] [4] [5] , a review exclusively dedicated to the expression of highly toxic genes is still missing. This paper presents and discusses updated strategies and genetic tools used to express in E. coli highly toxic genes. We define a highly toxic gene as a gene that, when introduced into an E. coli expression strain, causes cell death or severe cultivation and maintenance defects during the growth phase (prior to induction). Genes that exhibit toxic effects only when they are overproduced (after induction) are not the subject of this paper.
The main goal of the solutions presented in this paper is to enable E. coli cells to tolerate the highly toxic gene during the growth phase. After induction, efficient expression signals will ensure rapid and quantitative production of the highly toxic protein before cells die. For clarity purposes, we structured the paper in five main sections: manipulation of highly toxic genes transcriptional and translational control elements, manipulation of the coding sequence, manipulation of the copy number, addition of stabilizing sequences and empirical selection of E. coli strains. A short sixth section, named "Special expression protocols", is summarized in Table 3 .
All expression vectors and E. coli strains described in this paper are listed in Table 1 and Table 2 , respectively. We choose not to include "periplasmic secretion" in this review because of the heavily reviewed topic in the literature and because of the low expression-purification yields of this method.
I-MANIPULATION OF HIGHLY TOXIC GENES TRANSCRIPTIONAL AND TRANSLATIONAL CON-TROL ELEMENTS
Tight control of highly toxic genes transcription and translation is the first key for a successful expression in E. coli. Hereafter, we present and discuss transcriptional strategies that reduce the amounts of highly toxic genes mRNAs during the growth phase. These strategies include the phagemediated delivery of high specificity RNA polymerase, the use of an intrinsically tightly regulated promoter, the use of antisense, competitive, invertible and hybrid promoters, and the judicious positioning of strong transcription terminators. We will also discuss the use of "mRNA switch" mechanism to tightly control the translatability of highly toxic genes mRNAs. It is important to note that combinations of several strategies are very often needed in order to quantitatively express a highly toxic gene.
I.1. Phage-Mediated Delivery of Highly Selective T7 RNA Polymerase
In their first paper describing the design of an expression system based on the highly selective T7 RNA polymerase (T7 RNAP), Studier F.W. and Moffat B.A. stressed on the fact that small amounts of T7 RNAP provided from a single copy of phage T7 gene 1 are sufficient to direct high transcription levels from phage T7 gene ϕ10 promoter (T7 promoter) located on a multi-copy plasmid [6] . In the BL21(DE3) expression strain, T7 gene 1 is under the control of a promoter poorly shut off under repressive conditions (lacUV5 promoter). The basal level of T7-dependent transcription in this strain can be reduced by constitutive production of T7 lyzozyme, a natural inhibitor of T7 RNAP, using plasmids pLysS and pLysE [7] . Very often plasmids carrying highly toxic genes cannot be maintained in the BL21(DE3) strain regardless of the presence of lyzozyme-encoding plasmids. In some cases, transforming an E. coli strain that does not contain the T7 gene 1 can circumvent the problem of toxicity. Highly toxic gene expression is then induced at mid-log growth phase by delivering the T7 RNAP through infection by phage λ derivatives containing T7 gene 1. Infection by λ-derivatives λDE3 and λCE6 has been successfully used to express, respectively, the phage T4 translational repressor RegA and the phage T4 restriction endoribonuclease RegB and transcriptional activator MotA [8-9, Uzan, M., unpublished result]. Infection by an M13 derivative phage containing T7 gene 1 has been also described for the expression of the human immunodeficiency virus type 1 (HIV-1) protease [10] . Our experience with the phage T4 endoribonuclease RegB shows that the multiplicity of infection (MOI = number of infecting phage particles per E. coli cell) is a critical parameter that should be optimized in the range of 5-20 (Saida F., unpublished data).
I.2. Tight Regulation and High-Level Expression using the PBAD Promoter
A ratio of induction over repression of 1200 has been reached with a series of expression vectors containing the PBAD promoter of the araBAD arabinose operon and the gene coding the positive and negative regulator of this promoter, araC [11] (see Fig. (1) for a scheme of the regulation). The basal expression level of these vectors (pBAD, Invitrogen) can be reduced to very low levels in the presence of glucose and to extremely low levels in the presence of glucose-6-phosphate which catabolite represses the system more efficiently than glucose. Furthermore, the induction level can be controlled over a wide range of inducer (arabinose) concentrations. Despite the 8 to 10-fold reduced efficiency of E. coli RNA polymerase as compared to T7 RNAP, the pBAD system has been demonstrated to be very efficient to express highly toxic proteins because of the enrichment of E. coli cultures with plasmid-bearing cells during the growth phase. It has been used to express the highly toxic archeal RNase P in amounts compatible with structural studies [12, 13] . Recently, the benefits of the tightly regulated PBAD promoter and the efficient T7 expression system has been combined in the construction of an E. coli strain in which the chromosomal copy of the T7 RNAP is under the control of the PBAD promoter. Compared to BL21(DE3)pLysS, the new Arabinose-Induced host BL21-AI (Invitrogen) has a 4 fold lower basal level but a similar expression level after induction with 0.2 % w/v arabinose and 1 mM isopropyl-β-D-galactopyranoside (IPTG). When using an expression system under the control of the T7 promoter, BL21-AI strain should be the first strain to investigate if BL21(DE3)pLysS and BL21(DE3)pLysE strains fail to maintain the target gene.
I.3. The Antisense Strategy
Originally designed to express in E. coli the restriction endonuclease EcoRI after inactivation of its cognate methylase [14] , this strategy was used to express highly toxic genes with no known endogenous inhibitors. Bovine pancre- In BL21(DE3), the T7 RNAP gene is under the control of the lacUV5 promoter, a variant of the lac promoter with the point mutation (G to A at -9). This mutattion does not abolish its affinity to the cAMP/CAP activation complex. It only decreases it by 5-10 fold. Using the minimal M9 medium in the presence of 1 % Glucose , catabolic repression causes a decrease in the basal expression of T7 RNAP from the lacUV5 promoter.
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atic DNase I is an endonuclease that cleaves double-stranded DNA to yield 5'-phosphorylated polynucleotides [15] . The lack of success in sub-cloning this enzyme from an M13-derived cloning vector to an expression vector controlled by the tac promoter has not been circumvented by the use of the highly repressed λPL promoter [16] . Adding an antisense lac promoter downstream of the cloned gene was crucial to minimize the basal level of the highly toxic endonuclease [16] . In the presence of the lac inducer IPTG, the lac promoter directs the synthesis of antisense mRNAs that form RNA-duplexes preventing the translation of DNase I basal messengers. After derepression of the strong λPL promoter (heat inactivation of the cI857 repressor), significant amounts of DNase I were obtained despite the antisense inactivation of a fraction of the endonuclease mRNAs. The efficiency of this system could be optimized by tuning the induction level of the antisense promoter to the required level that neutralizes the basal expression of the highly toxic gene. An antisense promoter whose induction level depends on the inducer concentration (i.e. PBAD promoter) would be suitable.
I.4. The Use of Invertible Promoters
This strategy was initially described by Podhajska A.J. [17] and Hasan N. [18] . The promoter, flanked by two λ attachment sites (att), is cloned in a direction opposite to the gene to be expressed and inverted by inducing site-specific genetic recombination using λ integrase. This system was successfully used to express variable domains of a T-cell receptor (TCR) [19] . The expression vector contained all the relevant features of a lac-based expression system in addition to a lac promoter put within an invertible module. To deliver the λ integrase, the authors engineered a heat-inducible vector harboring the integrase gene under the tight control of both the λPL/cI857 system and the antisense ompA promoter. Compared to the previously described strategies, the use of invertible promoters permits a completely free choice of the promoter system that controls the expression of the highly toxic gene. Surprisingly, this strategy has not been adapted yet to the very efficient T7 RNAP-driven expression system.
I.5. The Use of Competitive Promoters
Introducing supplementary T7 promoters into E. coli BL21(DE3) cells would compete with the T7 promoter controlling the expression of the highly toxic gene and hence, would significantly decrease its basal expression. This idea was used to express the human immunodeficiency virus type 1 (HIV-1) protease [10] . The authors constructed a competitor plasmid by introducing the T7 promoter into the EcoRV site of plasmid pACYC184 [20] . The recombinant plasmid (pACYCT7pmt) was introduced into BL21(DE3) cells and maintained under the selection pressure of 30 µg/ml chloramphenicol. The cells were then transformed with the expression vector carrying the HIV-1 protease gene under the control of the same T7 promoter (parental plasmid pAR3040, selection marker: ampicillin resistance [21] ). Control cells (without the competitor plasmid) were also transformed with the expression vector. Only E. coli cells that contained the competitor plasmid yielded a large number of transformants in the presence of 100 µg/ml ampicillin. Furthermore, these double-transformed cells were able to express about 10 mg of active and soluble HIV-1 protease per liter of induced cells. The authors showed, by plasmid isolation techniques, that the copy number of the competitive plasmid was approximately twice as high as the copy number of the expression vector. This 2 to 1 ratio of T7 promoters (competitor to target) was apparently sufficient to suppress the toxicity of HIV-1 protease during the growth phase. Other highly toxic proteins, with a lower allowed basal expression level, may require higher ratios. The copy number of the competitor plasmid is therefore a parameter that should be optimized.
I.6. The Use of the Full-Length lac Promoter/Operator Region
Ratios of induction over repression as high as 1000 have been described, since the 1970s, for the full-length wild-type lac promoter/operator region [22] . This tight regulation is due to the interplay of three components: the catabolic repression mediated by the c-AMP-activated protein CAP, the binding of the lac repressor to the lac operator O1 site and the formation of stable loop structures due to the interaction of the lac repressor with one of the two auxiliary operators sites (O2 downstream of the coding region or O3 upstream of the CAP binding site, see (Fig. (2) top) and detailed reviews in [23] [24] ). pET vectors contain the very strong T7 promoter associated with only the lac operator O1 site. They lack both the CAP binding site and the O3 auxiliary operator (see Fig. (2) bottom) . This probably explains why it is not possible to completely shut off the expression of genes cloned in these vectors. Warren J.W. and coworkers designed a new expression vector (pLAC11) containing the entire lac control region between the start of the O3 auxiliary operator site to the end of the O1 site [25] . Using the β-galactosidase reporter system, they found that under repressed conditions plasmid pLAC11 exhibits a 84 fold lower expression level than the pET-21(+)/pLysS system whereas under induced conditions pLAC11 has only a 2 fold lower expression level. The ratio of induction over repression for pLAC11 was 590, close to the ratios described for the wild-type lac promoter/operator. The nearly complete shut off of gene expression under repressed conditions described here is very suitable for the expression of highly toxic genes because it significantly increases the number of E. coli cells surviving the growth phase and able to express the target gene. This enrichment significantly enhances the overall expression yield and shadows the 2 fold lost of induction level when compared to the pET expression system.
I.7. The Hybrid Promoter Strategy
The phage λPL promoter is a strong promoter in vivo that can be efficiently repressed by the cI repressor. A better repression was achieved by replacing the cI binding sites with sequences encoding the operator 2 (tetO2) of the Tn10 tetracycline resistance operon [26] . The resulting promoteroperator sequence called PLtet-O-1 is highly repressible by the Tet repressor and can be induced by adding anhydrotetracycline (aTc) to the culture [27] . aTC exhibits no antibiotic activity at the concentration required for full induction. When paired with ColE1 (50-70 copies), p15A (20-30 copies) and pSC101 (3-4 copies) replication origins, PLtet-O-1 exhibited induction over repression ratios of 2500, 3500 and 5000, respectively [27] . Similarly, a mutant of the lac promoter (Plac-8A) whose strength is 3-fold higher than that of the wild type Plac promoter has been combined with the binding site of the araC regulator (see section I.2). The new hybrid promoter, called Plac/ara-1 [27] , can be repressed by growing the cells in the presence of glucose and induced by adding IPTG and arabinose (see Fig. (3) ). An induction over repression ratio of 1800 was obtained when the promoter was paired with a pSC101 replication origin. It was successfully used to express the highly toxic restriction endonuclease Cfr9I in the absence of its cognate methyltransferase. PLtet-O-1 and Plac/ara-1 systems are commercially available under the Fig. (2) . Promoter-operator regions of the wild-type lac operon and the standard pET15b expression vector. +1 indicates the transcription start site. O1 and O3 are lac operator sites. Site O2, located in the coding sequence, is not shown. CAP: CAP binding site, SD: Shine-Dalgarno sequence of the lac operon, SD*: bacteriophage T7 gene ϕ10 Shine-Dalgarno sequence, T7 promoter: bacteriophage T7 gene ϕ10 promoter. The distance and the sequence between the SD and the ATG translation start site differ in the two systems. commercial names of pPROTet.E and pPROLar.A respectively (BD Biosciences).
I.8. Blocking Read-Through Transcription by Upstream Terminators
Several independent reports showed that some highly toxic genes cloned using the pET/T7 expression system cannot be maintained not only in the BL21(DE3) strain but also in E. coli strains that do not contain any source of T7 RNAP. Examples include the phage T4 ndd gene [28] , the thermostable esterase from Bacillus acidocaldarius [29] , the S. cerevisiae DNA polymerase δ [30] and our own observation with the phage T4 restriction endoribonuclease RegB [31] [32] . This phenomenon is, in part, explained by readthrough transcription mediated by E. coli RNA polymerase. This transcription initiates at cryptic promoters located upstream of the highly toxic gene promoter and continues through its coding sequence. mRNAs produced by this readthrough transcription are probably low in quantity but could yield critical amounts of the highly toxic proteins when they harbor a very efficient ribosome-binding site (RBS), i.e., the phage T7 gene ϕ10 RBS, found in pET expression vectors. This explanation is supported by our observation that the phage T4 regB gene cannot be cloned in the pET15b vector and maintained in a T7 RNAP-free strain unless the efficiency of the pET15b RBS is decreased by mutations that suppress key base-pairing between the target mRNA and the 16S rRNA [31] . To circumvent the read-through transcription problem without altering the efficiency of the RBS, strong transcription terminators upstream of the target gene promoter/coding sequence region are needed. The Rhoindependent transcription terminators T1 and T2 from E. coli rrnB operon [33] were inserted in tandem upstream of the T7 promoter controlling the expression of DNA polymerase gene [30] . E. coli rpoC terminator inserted upstream of the phage T4 regA control region was mandatory to quantitatively express this protein [8] .
I.9. Tightening the Translation by "mRNA Switch" Mechanism
Cossart and coworkers showed that the mRNA encoding the virulence-activating transcription factor PrfA from Listeria monocytogenes behaves as a thermosensor that regulates its own translation in a temperature-dependent manner [34] . At temperatures below 30°C, the ribosome-binding site of the prfA mRNA is sequestered into a secondary structure that prevents its binding to the ribosome and facilitates its degradation by intracellular ribonucleases. At temperatures above 37°C, the secondary structure is destabilized, the ribosomebinding site associates with the 16S rRNA and translation is initiated. The 5' leader region in the prfA mRNA was shown to be necessary and sufficient for this "mRNA switch" mechanism [34] . Interestingly, the same authors showed that the system can be reproduced in the gram-negative bacterium E. coli by coupling this 5' leader region to a target mRNA. It is therefore conceivable to couple this 5' leader region to the coding sequence of a highly toxic gene, to allow cells to grow at a temperature below 30°C and to induce protein expression by shifting the culture to a temperature above 37°C. For overexpression purposes, enhancement of the efficiency of the Shine-Dalgarno sequence present in the 5' leader region of the gene prfA, without compromising its thermodependence, is required. To our best knowledge, this strategy has not been investigated yet.
II. MANIPULATION OF THE CODING SEQUENCE
The strategies presented in this section target the coding sequence of the highly toxic gene. They report the suppression of an amber stop codon at position +1, the suppression of internal stop codons, the use of fusion proteins and the expression of the highly toxic product as two separate polypeptides.
II.1. Suppression of an Amber Stop Codon at Position +1
E. coli initiator tRNA has been mutated, in its anticodon region, from CAU to CUA [35] . The mutant tRNA has been shown to be amino-acetylated with glutamine instead of methionine. More interestingly, this mutant tRNA is formylated by E. coli methionyl-tRNA transformylase and exhibits features known to be important for its direction to the E. coli ribosomal site P [36] [37] . Using the chloramphenicol acetyltransferease gene in which the initator AUG codon was changed to the amber stop codon UAG, it was shown that the mutant tRNA can initiate protein synthesis at the stop codon both in vitro and in vivo [35] . Despite the fact that the efficiency of initiation at the UAG stop codon was 60 to 70 % as high as normal initiation at the AUG codon, these findings provide an interesting approach for tight control of highly toxic genes expression. By mutating the AUG initator codon of the target gene to UAG, one can transfer his highly toxic gene to the appropriate expression vector (pET system for example) using very standard cloning techniques and regular E. coli strains. Expression of the highly toxic gene can be obtained by using an E. coli strain pretransformed with a plasmid containing the mutant tRNA and the glutamine aminoacyl-tRNA synthetase (GlnRS) coding sequences [35] . Although these two genes have been used by the authors of the original work in two different plasmids and expressed constitutively, it would be judicious to trans- Fig. (3) . Architecture of the Plac/ara-1 hybrid promoter. +1 indicates the transcription start site. O1 is the lac operator site. Note that an additional O1 site is found at the 5' end. Os: a synthetic operator site, ara I1 and ara I2: binding sites of the araC repressor, SD: ShineDalgarno sequence.
fer the two genes to a single vector and to control the expression, at least, of the mutant tRNA using an inducible promoter.
II.2. Suppression of an Internal Stop Codon
The phage T4 ndd gene product is involved in the delocalization and disruption of E. coli nucleoid shortly after infection. It was not possible to clone the intact ndd gene under the control of tightly repressed promoters [38] . Sitespecific mutagenesis was used to convert the tyrosine UAC codon at position 121 to an UAG stop codon. E. coli strain PB4144 [39] carrying a temperature-sensitive allele of the supF suppressor was used to express the ndd gene. Cells grown at 42°C were able to tolerate the ndd gene under the control of the lacZ promoter. ndd expression was induced by shifting cultures growing exponentially from 42°C to 30°C and adding IPTG [38] .
II.3. Expression as Fusion Proteins
In this section, a removable fusion partner neutralizes the toxic effect of the target protein. It is important to note that the neutralizing partner is not necessarily a specific antidote that targets the highly toxic protein. A general polypeptide that causes the fusion to strongly interact with new partners, different from regular targets, may lead to a suppression of the toxic effect. The expression of the mammalian apoptosis modulator protein Bax in E. coli is an important example illustrating the rationale design of a neutralizing partner. The Bax protein leads to the lysis of E. coli cells at concentrations as low as 0.01% of total proteins [40] . Attempts to direct the expression of the protein to the periplasm failed to alleviate the toxicity [41] . When a 17-amino acids leader sequence encoding the GroEL-binding loop of the E. coli cochaperone GroES (S-loop) was fused to the N-terminus of Bax, the toxicity did not significantly decrease. However, when the expression is induced under conditions designed to enhance the expression of E. coli chaperones (addition of 2% ethanol), the culture expressing the S-loop-Bax fusion continued to grow, albeit more slowly. At the end of the fourhours induction period, the recovered biomass in the presence of 2% ethanol was more than 200% that obtained in the absence of ethanol. [41] . The polarity of the fusion (at the Nterminus) seems to be important. As the N-terminus leader peptide emerges from the ribosome, it directs the fusion immediately to GroEL. This prevents toxic segments of the protein from interacting with vital cellular components. Expression of antimicrobial peptides is another example of the use of neutralizing partners. Buforin II is a 21-amino acids antimicrobial agent from the amphibian Bufo bufo gargarizans. This very basic peptide is lethal to E. coli but can be produced as a fusion with a neutralizing acidic peptide [42] . The target peptide can be cleaved from its protecting part, at methionine positions, by using cyanogen bromide. In some cases the design of the fusion partner cannot be rationale. Empirical testing of many available fusion partners can be rewarding. E. coli-lethal cytokine receptor homology domain (CRH) of granulocyte-colony-stimulating factor (G-CSF) receptor was fused to different proteins including the maltose-binding protein MalE, thioredoxin and glutathione Stransferase [43] . The thioredoxin-fusion permitted the expression of significant amounts of active CRH.
II.4. Semi-Synthesis of Highly Toxic Proteins
Restriction endonuclease from Haemophilus parainfluenzae (HpaI) was produced using a semisynthetic approach that utilizes an intein, a protein-splicing element, to generate a reactive thioester at the C-terminus of a first recombinant polypeptide. Nucleophilic attack on this thioester by the Nterminal cysteine of a synthetic peptide led to the ligation of the two parts and to the production of active HpaI [44] . The first 223 amino acids were expressed in E. coli as three-part fusion protein to the intein and the chitin-binding domain (CBD). After purification on chitin beads, the thiol-induced cleavage released the first 223 amino residues with a thioester at the C-terminal alpha carbon. This product was ligated to a 28 amino acids synthesized peptide starting with an N-terminal cysteine. This strategy allows a free choice of the truncated polypeptide expression system. Provided that the synthesis of the second peptide is not limiting, the strategy can be adapted to produce large quantities of the highly toxic protein [45] . Constraints over the split site, dictated by the presence of a cysteine, can be bypassed by mutating a non-essential residue to cysteine.
III. MANIPULATION OF THE COPY NUMBER
Basal expression levels correlate directly with vectors copy numbers. While the stable maintenance of a highly toxic gene in E. coli is favored by the use of a low-copy number vector, its quantitative expression necessitates an increase in gene dosage prior to induction. Therefore, a system whereby the plasmid copy number is low but can be significantly increased prior to induction seems to be an attractive solution.
III.1. Thermal Control
At permissive temperatures, runaway-replication vectors can be maintained in E. coli at as low as one copy per chromosome. At restrictive temperatures, as a result of loss of replication control, their numbers rise enormously and approach 1000 copies per chromosome [46] . pOU61 is an example of runaway-replication plasmids [47] . RepA, CopA and CopB are responsible for the regulation of plasmid replication. Their expression is under the control of the thermosensitive allele of the cI repressor (cI857). Fig. (4) shows the thermal response of a system in which we cloned, for illustration, a non-toxic version of phage T4 RegB protein mutant under the control of the T7 promoter in vector pOU61. Expression of the wild type regB gene using this system was not possible in the BL21(DE3) strain, but yielded substantial amounts of the highly toxic endoribonuclease by combining the thermal control of the copy number with the phage-mediated delivery of T7 RNAP (λCE6, see section I.1). The overall expression yield did not, however, exceed 0.4 mg/L of culture because of the combination of three factors that are detrimental to E. coli normal growth: restrictive temperature, λCE6 infection and uncontrolled plasmid replication. A system in which the copy number could be raised to a number (~50) more compatible with cell physiology would have been more suitable.
III.2. Arabinose Control
T7-based expression vectors that allow copy number amplification from 1-2 copies per cell to 20-50 copies per cell have been developed (pETcoco-1 TM , Novagen). The expression vector is kept at 1-2 copies per cell by using the oriS and repE elements of the F episome together with the parABC partition determinants. 20-50 copies per cell are obtained by using the RK-2 derived trfA replicator that acts at oriV. Switching from low to high copy numbers is achieved by adding arabinose, which tightly control the expression of the trfA gene (see section I.2). Similarly, Bowers designed a host/vector system that allows tight and uniform modulation of the copy number of plasmids with a γ replication origin (ori) [48] . The regulation is achieved through arabinose-inducible expression of the required Rep protein (π) whose gene was inserted into the chromosome of E. coli under the control of the PBAD promoter. The system was successfully used to express the highly toxic colicin E3 in the absence of its cognate immunity protein [48] .
III.3. Use of the "CopyCutter" E. coli Strain
The copy number of ColE1-type plasmids is controlled by the pcnB (plasmid copy number) gene. This gene, constitutively expressed in E. coli, was deleted and replaced by a modified pcnB gene under the control of a patented inducible promoter, creating the CopyCutter TM EPI400 TM strain (EPICENTRE). Under repressed conditions, this strain decreases the copy number of pUC19 plasmid from ~216 to ~9 copies. When induced, the copy-number is restored to ~200 copies per cell [49] . Similarly, this strain decreases the copy number of the T7-based expression vector pET9 from 33 to 9 copies. When induced, the copy number reaches 19 per cell. This system was successfully used to clone a promoterless 461-bp PCR fragment, containing the phage T4 regB gene, into the T7 expression system pET11a. When the ligation mixture was electroporated into a standard E. coli strain, 19 clones were obtained. 17 of them contained no inserts and 2 had large deletions. Using the "CopyCutter" cells under repressed conditions, all 29 clones obtained were recombinant [49] . The author, however, did not specify the efficiency of regB expression, if there is any, using the obtained recombinant plasmids. Table 2 lists other useful E. coli strains that manipulate the copy number.
IV. ADDITION OF STABILIZING SEQUENCES
The main problems associated with the expression of highly toxic genes is plasmid instability during the growth phase. Because of their physiological advantages, plasmidfree cells quickly overtake the culture. This phenomenon dramatically decreases the expression yield because only a very small fraction of the surviving cells retained its ability to express the target gene. To circumvent this problem, expression vehicles carrying genes that cause cell death upon plasmid loss are required. Two E. coli loci are of particular interest: parB and ccd. The parB locus (hok/sok) cell death program involves a 52 amino acids membrane damaging protein (Hok) whose mRNA is very stable but translationaly inactive. sok is a highly instable antisense RNA that binds the hok mRNA leader region. In plasmid-free cells, the pool Fig. (4) . Production of RegB R52L using the thermo-responsive pOU61 system. Left: architecture of the pOU61 plasmid. repA, copA and copB: replication regulators; bla: ampicillin-resistance determinant; T7 ϕ10, RBS ϕ10 and T7T: bacteriophage T7 gene ϕ10 promoter, ribosome-binding site and T7 terminator respectively; (His)6: six histidines-tag. Right: SDS-PAGE analysis of the expression system. Lane a: before induction. Lane b: incubation for 30 min at 42°C then shift to 37°C for 2 hours 30 min in the presence of 1 mM IPTG. The arrow indicates the RegB band.
of sok decays rapidly. This leads to the processing of the 3' end of hok and the production of an active transcript [50] . The ccd locus (ccdA/ccdB) involves a proteolytically stable CcdB protein that inhibits DNA gyrase [51] . CcdA binds to CcdB and blocks its action. In plasmid-free cells, the pool of CcdA decays rapidly because of its short half-life. This leads to cell death. Expression of the highly toxic phospholipase D cloned in a standard pET vector illustrates this method. Without stabilization loci, the percentage of plasmid-bearing cells was as low as 10% [52] . When the parB or the ccd loci were added to the plasmid, this percentage reached nearly 100 % just before induction.
V. EMPIRICAL SELECTION OF E. coli STRAINS EXPRESSING HIGHLY TOXIC GENES
In the previous sections, we described the major strategies that should be tested in order to express, in E. coli, highly toxic products. The rationale design of these strategies is mainly based on the very well known genetics of the bacterium. The important number of parameters that should be taken in account illustrates the complexity of the biological process leading to a quantitative expression of highly toxic genes. In some cases, this whole complexity can be encompassed by empirical selection of those E. coli strains that tolerate the expression of the highly toxic product. This takes advantages of the silent mutations that accumulate over generations of growth and that could be selected for the advantage they confer to E. coli in the presence of a detrimental recombinant gene. Hence, a strain as standard and as stable as BL21(DE3) should be carefully analyzed after transformation for phenotypic differences on agar plates, for differences in the basal expression levels of T7 RNAP using standard reporter genes, for differences in the kinetic of accumulation of the recombinant product. HIV-2 protease could not be maintained under the control of the T7 promoter in the BL21(DE3)pLysS supplied by Novagen [53] . However, a BL21(DE3)pLysS variant empirically selected for its ability to express HIV-1 protease, was shown to tolerate HIV-2 protease. The BL21(DE3)pLysS variant was shown to have a slower rate of mRNA accumulation when compared to the commercially available strain [53] . A complete protocol for selection of useful variants of BL21(DE3) is described by Miroux B. and Walker J.E. [54] . The authors described the selection of two derivatives strains called C41(DE3) and C43(DE3) that tolerated the expression of some highly toxic genes. In the case of the C41(DE3) strain, not only basal recombinant mRNA levels were five times as low as in BL21(DE3), they also accumulated twice as slow after induction. A third variant called BL21(DE3)NH was recently isolated during attempts to express unstable genes originating from Mycobacterium tuberculosis [55] . This variant was confirmed to be E. coli by standard biochemical and cultural tests even though it formed small opaque colonies and was shown, using scanning electron microscopy, to have extremely long bacillary shapes [55] . The mechanism by which this variant tolerates the expression of highly toxic genes is unknown. Table 3 summarizes special expression protocols that could be used to improve the expression of highly toxic genes using the standard pET/BL21(DE3) expression system.
VI. SPECIAL EXPRESSION PROTOCOLS

CONCLUSION
We reviewed in this paper special strategies and genetic tools useful for the expression of highly toxic genes. Although we were probably not exhaustive, the set of solutions summarized in this review highlight two important points: the need to characterize the level of toxicity of problematic genes not only qualitatively but also quantitatively (using standard plasmid stability tests for example) and the need to tune the tightness of the inducible expression system to match the basal expression level that E. coli tolerates. Although the desirable tightness can be achieved by combining many rationale strategies based on the well-known genetics of E. coli, empirical selection of E. coli strains can be rewarding and time-saving.
For those unfortunate cases, where an extensive investigation of E. coli expression systems did not circumvent the toxicity problem, there are several alternative strategies, in vitro and in vivo, that should be tested. The in vitro strategy is based on cell-free translation systems. The Rapid Translation System (RTS) uses enriched E. coli lysate to couple in vitro transcription and translation reactions. This system has been reviewed in a previous issue of this journal [61] . Large protein amounts, compatible with structural analysis, can be obtained by using a continuous flow of an input buffer (containing amino acids, adenosine triphosphate and guanosine triphosphate) and by removing continuously the newly synthesized polypeptide [62] . Commercially available kits (Roche Diagnostics, Invitrogen) have been used to successfully express 32 different rickettsial proteins (many of these proteins are known to be highly toxic to E. coli) [63] . Alternative in vivo strategies include the expression of highly toxic genes in yeast, in mammalian cells and in insect cells. In these strategies, the abolition of the toxic problem is directly related to the differences between the physiology of a prokaryotic cell and the physiology of a eukaryotic cell. Yeast Saccharomyces cerevisiae, the most sophisticated eukaryotic model for recombinant DNA, expressed many highly toxic virulence proteins from bacterium Yersinia Pestis [64] . The methylotrophic yeast Pichia pastoris combines the advantages of a eukaryotic cell physiology with an excellent expression yield (see reference [65] ). Expression in mammalian cells is an additional strategy for the expression of toxic genes. Chinese Hamster ovary (CHO) and nonsecreting myeloma cells are very popular in recombinant protein expression [66] . The use of mammalian cells, however, suffers from several limitations including cultivation complexity, expensiveness and low expression yields. In contrast, insect cells transformed by baculovirus vectors are easier to manipulate, more resistant and more productive [67] . Interestingly, an ecdysone-inducible system has been recently developed in insect cells [68] . This system tightly regulates the transcription of the recombinant gene in insect cells using an ecdysone agonist as inducer. The highly toxic diphteria toxin (DT) has been expressed using this system [68] .
